Eastman Chemical SVP granted options and RSUs

McAlindon Julie A. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

McAlindon Julie A. reported acquisition or exercise transactions in this Form 4 filing.

Eastman Chemical senior vice president Julie A. McAlindon received new equity awards on February 24, 2026. She was granted 24,364 employee stock options, which become exercisable in three equal parts on February 24, 2027, February 24, 2028, and February 24, 2029.

She was also awarded 3,352 restricted stock units, with each unit representing the right to receive one share of common stock. These units will vest and pay out in unrestricted shares on February 24, 2029, subject to her continued employment.

Insider Trade Summary

Grant/Award: 27,716 shares

Grant/Award 2 txns

Insider McAlindon Julie A.

Role SVP, Regions & Chf SupChn Ofcr

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (right to buy)	24,364	$0.00	$0.00
Grant/Award	Restricted Stock Units	3,352	$0.00	$0.00

Holdings After Transaction: Employee Stock Option (right to buy) — 24,364 contracts (Direct); Restricted Stock Units — 3,352 contracts (Direct)

Footnotes (3)

1. F1. One-third of the options become exercisable on February 24, 2027, February 24, 2028, and February 24, 2029, respectively.
2. F2. Each restricted stock unit represents a contingent right to receive one share of issuer common stock.
3. F3. The restricted stock units will vest and payout in unrestricted shares of Company common stock on the third anniversary of the grant date, February 24, 2029, subject to continued employment.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did Eastman Chemical (EMN) grant to Julie A. McAlindon?

Eastman Chemical granted Julie A. McAlindon 24,364 employee stock options and 3,352 restricted stock units. These awards increase her long-term equity-based compensation and link a portion of her pay to Eastman Chemical’s future share performance and continued service.

How do the new stock options for Eastman Chemical (EMN) executive Julie McAlindon vest?

Julie McAlindon’s 24,364 stock options vest in three equal installments. One-third becomes exercisable on February 24, 2027, another third on February 24, 2028, and the final third on February 24, 2029, creating a multi-year retention and incentive schedule.

When will Julie McAlindon’s Eastman Chemical (EMN) restricted stock units vest?

Julie McAlindon’s 3,352 restricted stock units will vest and pay out in unrestricted Eastman Chemical common shares on February 24, 2029. Vesting is conditioned on her continued employment through that date, aligning her incentives with longer-term company performance.

What does each restricted stock unit mean in Eastman Chemical (EMN)’s Form 4 for Julie McAlindon?

Each restricted stock unit reported for Julie McAlindon represents a contingent right to receive one share of Eastman Chemical common stock. Once vested on February 24, 2029, these units convert into unrestricted shares, assuming she remains employed by the company.

Is Julie McAlindon’s Form 4 for Eastman Chemical (EMN) a stock purchase or a grant?

Julie McAlindon’s Form 4 reflects equity grants, not market purchases. She acquired 24,364 stock options and 3,352 restricted stock units as compensation awards, with a reported grant price of $0.00 per unit and specified future vesting and exercisability dates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/26/2026 - 04:03 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McAlindon Julie A.

(Last) (First) (Middle)

200 S. WILCOX DRIVE

(Street)

KINGSPORT TN 37660

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EASTMAN CHEMICAL CO [ EMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Regions & Chf SupChn Ofcr

3. Date of Earliest Transaction (Month/Day/Year)
02/24/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$77.12	02/24/2026		A		24,364		02/24/2027(1)	02/23/2036	Common Stock	24,364	$0	24,364	D
Restricted Stock Units	(2)	02/24/2026		A		3,352		(3)	(3)	Common Stock	3,352	$0	3,352	D

Explanation of Responses:

1. One-third of the options become exercisable on February 24, 2027, February 24, 2028, and February 24, 2029, respectively.

2. Each restricted stock unit represents a contingent right to receive one share of issuer common stock.

3. The restricted stock units will vest and payout in unrestricted shares of Company common stock on the third anniversary of the grant date, February 24, 2029, subject to continued employment.

Remarks:

	/s/ Mark D. Austin, by Power of Attorney for Julie A. McAlindon	02/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.